Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Outstanding
Ratios

BioCorRx (BICX) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for BioCorRx (BICX) over the last 15 years, with Q3 2025 value amounting to $186866.0.

  • BioCorRx's Accumulated Depreciation & Amortization rose 1473.6% to $186866.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $186866.0, marking a year-over-year increase of 1473.6%. This contributed to the annual value of $175574.0 for FY2024, which is 2225.92% up from last year.
  • BioCorRx's Accumulated Depreciation & Amortization amounted to $186866.0 in Q3 2025, which was up 1473.6% from $183468.0 recorded in Q2 2025.
  • In the past 5 years, BioCorRx's Accumulated Depreciation & Amortization registered a high of $186866.0 during Q3 2025, and its lowest value of $71222.0 during Q1 2021.
  • Over the past 5 years, BioCorRx's median Accumulated Depreciation & Amortization value was $130769.0 (recorded in 2023), while the average stood at $131029.4.
  • As far as peak fluctuations go, BioCorRx's Accumulated Depreciation & Amortization surged by 43463.97% in 2021, and later soared by 1473.6% in 2025.
  • Over the past 5 years, BioCorRx's Accumulated Depreciation & Amortization (Quarter) stood at $91708.0 in 2021, then rose by 28.65% to $117979.0 in 2022, then rose by 21.72% to $143608.0 in 2023, then rose by 22.26% to $175574.0 in 2024, then grew by 6.43% to $186866.0 in 2025.
  • Its Accumulated Depreciation & Amortization stands at $186866.0 for Q3 2025, versus $183468.0 for Q2 2025 and $179338.0 for Q1 2025.